Project Aim(s): To execute preclinical testing of an HDAC3-specific inhibitor for disease prevention in Huntington's disease (HD).
Disease area
Neurodegenerative Disease
Field of research
Clinical Research
Principal Investigator/ Researcher Names
Prof. Robert Lahue
Institution
NUI Galway
Funding body
EHDN
Grant Awarded (€)
49,914
Start date
Project completed
No
End/expected end date
Are you looking to Recruit Research Participants?
No
Additional Comments
Published: https://www.nature.com/articles/s41598-017-05125-2